January 31, 2018 / 6:34 PM / in 24 minutes BRIEF-Nemaura Announces Positive Results For Its Sugarbeat European Clinical Program Reuters Staff 
Jan 31 (Reuters) - Nemaura Medical Inc: 
* NEMAURA ANNOUNCES POSITIVE RESULTS FOR ITS SUGARBEATÂ® EUROPEAN CLINICAL PROGRAM 
* NEMAURA MEDICAL - SUGARBEAT IS EXPECTED TO LAUNCH IN UK, FOLLOWED BY OTHER TERRITORIES UPON ACHIEVING CE APPROVAL, WHICH IS ANTICIPATED IN COMING MONTHS 
* NEMAURA MEDICAL INC - ADDITIONAL CLINICAL STUDIES ARE PLANNED FOR SUGARBEAT FOR FDA APPROVAL IN U.S. 
* NEMAURA MEDICAL - ADDITIONAL CLINICAL STUDIES ARE PLANNED FOR SUGARBEAT FOR FDA APPROVAL IN U.S., AND FOR USE OF SUGARBEAT IN CRITICAL CARE SETTINGS Source text for Eikon: Further company coverage: